Logo - springer
Slogan - springer

Biomedical Sciences - Pharmacology & Toxicology | Medicinal Chemistry Research – incl. option to publish open access (Editorial Board)

Medicinal Chemistry Research

Medicinal Chemistry Research

Editor: Stephen J. Cutler

ISSN: 1054-2523 (print version)
ISSN: 1554-8120 (electronic version)

Journal no. 44

$99.00 Personal Rate e-only for the Americas
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

1 Volume(-s) with 12 issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy


Stephen J. Cutler, College of Pharmacy, University of South Carolina, SC, USA

Senior Editors:

Francisco Leon, Medicinal Chemistry, College of Pharmacy, University of Florida, FL, USA

Christopher McCurdy, Medicinal Chemistry, College of Pharmacy, University of Florida, FL, USA

Associate Editors:

Paulo Carvalho, Pharmaceutical Sciences, Feik School of Pharmacy, University of the Incarnate Word, San Antonio, Texas, USA

Young Kim, School of Arts and Sciences, Bluefield State College, Bluefield, WV, USA

Anand Sridhar, Wegmans School of Pharmacy, St. John Fisher College, Rochester, NY, USA

Editorial Board:

Seth Y. Ablordeppey, Tallahassee, FL, USA
Paul S. Anderson, West Point, PA, USA
Shridhar V. Andurkar, Downers Grove, IL, USA
Livio Brasili, Modena, Italy
Paulo Carvalho, Baltimore, Maryland

James M. Cook, Milwaukee, WI, USA
Elias J. Corey, Cambridge, MA, USA
Erik De Clercq, Leuven, Belgium
Malgorzata Dukat, Richmond, VA, USA
Francisco Jesús Estévez Rosas, Las Palmas de Gran Canary, Gran Canary, Spain
Magid Abou-Gharbia, Princeton, NJ, USA
Robert Hill, Christchurch, New Zealand
Richard Hudson, Toledo, OH, USA
Malliga Iyer, Rockville, MD, USA
Ken Kanematsu, Nagoya, Japan
Glen E. Kellogg, Richmond, VA, USA
Lemont Kier, Richmond, VA, USA
Gérard Leclerc, Grenoble, France
Francisco A. Macias, Cádiz, Spain
George Majetich, Athens, GA, USA
Ignacio Brouard Martin, La Laguna, Tenerife, Spain
Duane D. Miller, Memphis, TN, USA
Kenner Rice, Bethesda, MD, USA
Bryan Roth, Cleveland, OH, USA
A.K. Saxena, Lucknow, India
Augusto Rivera Umana, Bogota, Columbia
Cornelis J. Van der Schyf, Pocatello, ID, USA
Richard Westkaemper, Richmond, VA, USA

Editor Emeritus:

Richard Glennon, Richmond, VA, USA

Meet the Editor-in-Chief: 

Stephen J. Cutler

Stephen J. Cutler, Ph.D., is a broadly trained medicinal chemist and behavioral pharmacologist whose research focuses on the design, synthesis, discovery and development of drugs to treat various disorders, including those of the central nervous system (CNS). During his career, Dr. Cutler has received more than $30,000,000 from various federal agencies including the NIH, NSF, DoD, CDC, NASA, and the USDA. He is the author or co-author of more than 45 patents (US and international), 120 peer-reviewed publications, 3 books, 20 book chapters, 39 published abstracts, and 62 invited presentations. Presently, Dr. Cutler serves as the Dean and Professor of the University of South Carolina College of Pharmacy.

Meet the Senior Editors 

Francisco León

Dr. León received his degree in Chemistry from National University of Colombia, Bogota, Colombia. He obtained his doctoral degree in organic chemistry, at La Laguna University, Tenerife, Spain. Dr. León’s research interest consist of the exploration of the chemistry expressed through natural products from different natural sources, such as, plants and fungi. As well as the synthesis and semi-synthesis of bioactive natural compounds. He is author or co-author of around eighty peer-review publications. Dr. León holds currently a faculty position as Assistant Scientist at the Department of Medicinal Chemistry in the College of Pharmacy, University of Florida.

Christopher R. McCurdy

Christopher R. McCurdy, PhD, FAAPS is a broadly trained medicinal chemist, behavioral pharmacologist and pharmacist whose research focuses on the design, synthesis and development of drugs to treat pain and drug abuse. For over 20 years, much of his research has focused on opioid, Neuropeptide FF, and sigma receptor ligand/probe design, synthesis, pharmacological evaluation and development. He has been successful in discovering unique and selective tools for sigma receptors, NPFF receptors and opioid receptors. He is an internationally recognized expert on Kratom (Mitragyna speciosa), that is under investigation for opioid withdrawal syndrome. A significant portion of his career has been dedicated to the development of novel sigma receptor ligands, in collaboration with a variety of interdisciplinary groups, to generate and optimize selective ligands which could serve as critical experimental tools, and more recently, as potential medication development leads to attenuate the effects of cocaine, methamphetamine and pain. Most notably, he has developed a PET/MR imaging diagnostic agent for visualizing the origins of chronic, neuropathic pain by interacting with sigma receptors at the site of nerve damage. Human Phase 1 clinical trials are currently underway at Stanford University. In addition to his discovery chemistry roles, McCurdy serves as the director of the UF Translational Drug Development Core. He is a member of the Editorial Advisory Board for the Journal of Medicinal Chemistry and is a Senior Editor for Medicinal Chemistry Research. Dr. McCurdy is servings as the 2017-2018 President of the American Association of Pharmaceutical Scientists (AAPS) and also serves as the Co-Chair of the Special Interest Group on Drug Design and Discovery (DDD) of the International Pharmaceutical Federation (FIP). He has published over 100 peer-reviewed manuscripts and has been issued 4 patents.

Meet the Associate Editors 

Anand Sridhar

Dr. Sridhar received his baccalaureate degree in Pharmaceutical Sciences from Mumbai University in Mumbai, India. He obtained his doctoral degree in Medicinal Chemistry, at the University of Mississippi, on projects involving organic synthesis, medicinal chemistry, chemical toxicology, and structure-based drug design. Dr. Sridhar is currently an Assistant Professor, Pharmaceutical Sciences, St. John Fisher College, Rochester, NY.

Paulo Carvalho

Dr. Paulo Carvalho was a compounding pharmacist in Brazil, where he also earned his Ph.D. in Medicinal Chemistry from Universidade de São Paulo. Dr. Carvalho’s research interests include natural products chemistry, synthesis of drugs against tropical diseases and HPLC-MS analysis of drugs and their metabolites in biological fluids. He is currently an Associate Professor at the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX.

Young Kim

P_A56146_MCR_AssoEditorPic_Young Kim_95x120px
Dr. Kim received his baccalaureate in Biology and doctoral degree in Medicinal Chemistry at the University of Mississippi. His doctoral research projects were involved medicinal/organic chemistry with study on structural-activity relationship on bio-active natural products. Currently, Dr. Kim is an Assistant Professor of Chemistry, Bluefield State College, Bluefield, WV. Away from his teaching and researching, he likes to travel and is a big Ole Miss Sports fan.

Read this Journal on Springerlink

For authors and editors

  • Journal Citation Reports®
    2017 Impact Factor
  • 1.607
  • Aims and Scope

    Aims and Scope


    Medicinal Chemistry Research is a journal for the prompt disclosure of novel experimental achievements in the many facets of drug design, drug discovery, and the elucidation of mechanisms of action of biologically active compounds. Articles are sought which emphasize research in chemical biological relationships, especially on: structure-activity relationships, investigations of biochemical and pharmacological targets of drug action, and correlations of structures with the mode of action of biologically active compounds. Studies will be welcomed that increase our understanding of biochemical interactions between drug molecules, ions, free radicals, and sterically important sections of macromolecular targets.

    The journal will strive to publish short papers of approximately 8-10 pages within two months of acceptance. A rapid peer-reviewing system will be maintained by the Editors. In addition, occasional short "New Trends" articles will appear at the invitation of the Editors. These articles will be solicited from the leading researchers in all fields of medicinal chemistry.

    Medicinal Chemistry Research is a Journal dedicated to medicinal plants and to bioactive natural products of plant origin. It publishes original contributions in seven major areas:

    1. Synthesis of bioactive compounds
    2. Docking, molecular modeling, QSAR, SAR, and computational studies of bioactive interactions
    3. Characterization of active ingredients of medicinal plants/identification of bioactivity in plant extracts
    4. Identification of targets and mechanism of activity of plant extracts
    5. Chemistry and biochemistry of bioactive natural products of plant origin
    6. Critical reviews of the historical, clinical and legal status of medicinal plants, and accounts on topical issues.

    Bibliographic Data
    First published in 1991
    1 volume per year, 12 issues per volume
    Format: 15,5 x 23,5 cm
    ISSN 1054-2523 (print)
    ISSN 1554-8120 (electronic)

    Bibliographic Data
    First published in 1991
    1 volume per year, 12 issues per volume
    Format: 15,5 x 23,5 cm
    ISSN 1054-2523 (print)
    ISSN 1554-8120 (electronic)


  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors--pdf (pdf, 375 ...
  • Research Data Policy

    Research Data Policy


  • Ed.Manager - Tutorial for Authors (pdf, ...
  • Ed.Manager - Tutorial for Reviewers (pdf...
  • Open Choice

    Birkhäuser Open Choice


  • Author Academy: Training for Authors
  • Author Services
  • Copyright Information

    Copyright Information


    Copyright Information

    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Springer (respective to owner if other than Springer) becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to Springer effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author's accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com".

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at link.springer.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via link.springer.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the publisher (respective the copyright owner if other than Springer). The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on link.springer.com or on springerimages.com and click on the permissions link or go to copyright.com, then enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.

    © Springer Science+Business Media New York

Services for the Journal

Alerts for this journal


Get the table of contents of every new issue published in Medicinal Chemistry Research.

Additional information